FoxM1c-miR-149-FoxM1b/1c负反馈环路在结肠癌血管生成中的调控作用及分子机制研究
批准号:
81572457
项目类别:
面上项目
资助金额:
57.0 万元
负责人:
褚晓源
依托单位:
学科分类:
肿瘤复发与转移
结题年份:
2019
批准年份:
2015
项目状态:
已结题
项目参与者:
薛利军、冒晓蓓、刘小北、耿建、陈亚楠、杨丹、谢涛
中文摘要
靶基因-miRNA交互调控参与人多种生理和病理过程,其在结肠癌血管生成中的作用有待深入探索。本课题组前期已报道:转录因子叉头框蛋白M1(forkhead box M1,FoxM1)促进结肠癌增殖、侵袭和转移等恶性表型形成,并受miR-149负向调控。然而,FoxM1在结肠癌血管生成中的作用及分子机制并不清楚。课题组预实验发现:FoxM1与结肠癌组织微血管密度、VEGF和MMP-2表达正相关;软件分析显示miR-149核心启动子区含两个FoxM1c结合位点而没有FoxM1b结合位点。基于此,我们提出科学假说:FoxM1c-miR-149-FoxM1b/1c负反馈环路可能是结肠癌血管生成的重要分子机制。本研究拟采用位点突变、免疫共沉淀、基因过表达及RNA干扰等技术,分别从细胞和活体动物水平深入阐明上述负反馈环路在结肠癌血管生成中的作用和分子机制,为进一步筛选和开发抗血管治疗新靶标提供理论依据。
英文摘要
The cross-regulation between target genes and microRNA is involved in many human physiological and pathological processes, whereas its roles in colon cancer angiogenesis remain further exploration. As we reported, the up-regulation of transcription factor forkhead box M1 (FoxM1) promoted the formation of malignant phenotypes of proliferation, invasion and metastasis in colon cancer, which was negatively regulated by miR-149. However, the functions and related molecular mechanisms of FoxM1 in colon cancer angiogenesis are still unclear. Our team has found out that the level of FoxM1 positively correlates with those of microvessel density, VEGF and MMP-2 in cancer tissues, and that two potential FoxM1c-binding but not FoxM1b-binding sites exist in the core promoter region of miR-149 by bioinformatics softwares. Therefore, a scientific hypothesis is raised that a negative feedback loop of FoxM1c-miR-149-FoxM1b/1c should play key roles in colon cancer angiogenesis. In this study, many techniques including site mutation, chromatin immunoprecipitation, gene over-expression and RNA interference are to be used in cultured cell lines and small live animal models, respectively, to deep elucidate the roles and molecular mechanisms of the mentioned negative feed back loop. Our study may help to provide theoretical evidences for further screening and developing novel therapeutic anti-angiogenesis targets against colon cancer.
血管生成对肿瘤的生长和转移具有重要作用,而结肠癌血管生成的调控机制尚待探索。本项目通过分子生物学、细胞水平、动物水平等实验,筛选出了靶向FOXM1的关键miRNA--miR-6868-5p,发现miR-6868-5p通过靶向FOXM1进而抑制IL-8产生,从而抑制结肠癌血管生成。此外,进一步研究表明FOXM1通过促进EZH2表达,增加pri-miR-6868启动子区H3K27me3抑制miR-6868-5p表达,从而形成反馈环路。本课题揭示了miR-6868-5p与FOXM1间的调控环路,并阐明了该环路在结肠癌血管生成中的作用。研究结果为结肠癌血管生成提出了新的机制,并为结肠癌治疗提供了潜在的治疗靶点。本项目资助获得的研究成果已发表SCI论文6篇,其中影响因子5.0以上4篇;参加国内学术交流一次,获大会优秀论文;培养硕士研究生4名,博士研究生1名。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications.
microRNA在肿瘤血管生成中的调节作用及其临床意义的新见解
DOI:
10.1186/s12943-018-0766-4
发表时间:
2018-02-07
期刊:
Molecular cancer
影响因子:
37.3
作者:
[Wang Y, Wang L, Chen C, Chu X]
通讯作者:
Chu X
Role of the zinc finger and SCAN domain-containing transcription factors in cancer
锌指和含有 SCAN 结构域的转录因子在癌症中的作用
DOI:
--
发表时间:
2019
期刊:
American Journal of Cancer Research
影响因子:
5.3
作者:
[Huang Mengxi, Chen Yanyan, Han Dong, Lei Zengjie, Chu Xiaoyuan]
通讯作者:
Chu Xiaoyuan
Chemotherapy is associated with increased survival from colorectal signet ring cell carcinoma with distant metastasis: A Surveillance, Epidemiology, and End Results database analysis
化疗与远处转移的结直肠印戒细胞癌生存率增加相关:监测、流行病学和最终结果数据库分析
DOI:
10.1002/cam4.2054
发表时间:
2019-04-01
期刊:
CANCER MEDICINE
影响因子:
4
作者:
[Shi, Tao, Huang, Mengxi, Chu, Xiaoyuan]
通讯作者:
Chu, Xiaoyuan
Dysregulation of miR-6868-5p/FOXM1 circuit contributes to colorectal cancer angiogenesis.
miR-6868-5p/FOXM1 回路失调有助于结直肠癌血管生成
DOI:
10.1186/s13046-018-0970-5
发表时间:
2018-11-28
期刊:
Journal of experimental & clinical cancer research : CR
影响因子:
--
作者:
[Wang Y, Wu M, Lei Z, Huang M, Li Z, Wang L, Cao Q, Han D, Chang Y, Chen Y, Liu X, Xue L, Mao X, Geng J, Chen Y, Dai T, Ren L, Wang Q, Yu H, Chen C, Chu X]
通讯作者:
Chu X
Targeting KDM1A attenuates Wnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma
靶向 KDM1A 减弱 Wnt/β-catenin 信号通路以消除肝细胞癌中索拉非尼耐药的干细胞样细胞
DOI:
10.1016/j.canlet.2017.03.038
发表时间:
2017-07-10
期刊:
CANCER LETTERS
影响因子:
9.7
作者:
[Huang, Mengxi, Chen, Cheng, Chu, Xiaoyuan]
通讯作者:
Chu, Xiaoyuan
共 6 条
去泛素化酶OTUB2与转录因子GATA2正反馈环路促进结肠癌转移的机制研究
-
批准号:82072725
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:褚晓源
-
依托单位:
MZF1/SETD1A-FoxM1正反馈环路促进结直肠癌侵袭转移的机制研究
-
批准号:81872042
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2018
-
负责人:褚晓源
-
依托单位:
叉头框蛋白M1(FOXM1)通过转录激活存活素(survivin)基因表达而参与结肠癌肝转移表型形成的分子机制研究
-
批准号:81272394
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2012
-
负责人:褚晓源
-
依托单位:
国内基金
海外基金